National Advertising Division Finds Hims & Hers Has Support for Combination Efficacy Message; Recommends Modification or Discontinuance of Other Claims
Kenvue (KVUE) Stock Looks Cheap On Cash Flow But Fair On Earnings
Should Zyrtec’s New Drug-Free Allergen Shield Spray Launch Require Action From Kenvue (KVUE) Investors?
Will a Neutrogena boycott by Hayden Panettiere's fans work?
Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh Test
Essity acquires feminine care business in Brazil
Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284M
Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects
UBS Maintains Neutral on Kenvue, Lowers Price Target to $19
How Reddit and Wall Street See Kenvue as Buyout Nears
Kenvue Stock Falls 2.7% as Growth Arrives With Thinner Margins
KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise
Kenvue second quarter results fall short of expectations, sending shares lower
Kenvue (KVUE) Lags Q2 Earnings and Revenue Estimates
Kenvue (NYSE:KVUE) Falls After Q2 Earnings Miss as Kimberly-Clark Deal Looms
Kenvue Reports Second Quarter 2026 Results
Kenvue Benefits From Consumer Health Trends and Margin Expansion
Kenvue Increases Quarterly Cash Dividend
What Are Wall Street Analysts' Target Price for Kenvue Stock?
Kenvue Increases Quarterly Dividend By 1.2% To $0.21 Per Share
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.